Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 816 results for "bayer healthcare"

Bayer's Stivarga endorsed for gastrointestinal stromal tumors

New studies planned to further expand indications for Xarelto

German pharma major Bayer (BAYN: DE) and partner Janssen Research & Development, a unit of US health care giant Johnson & Johnson (NYSE: JNJ), says they are expanding the global clinical development program for the oral Factor Xa inhibitor Xarelto ... Pharma Letter, 1 day ago

14 images for bayer healthcare, 24 minutes ago
Mobihealthnews, 3 days ago
FierceMedicalDevices, 2 days ago
OncLive, 1 month ago
Digital Journal, 1 month ago, 1 month ago
Drug Discovery and Development, 1 month ago
Animal Pharm News, 1 month ago
Drug Discovery and Development, 1 month ago
Yahoo! News Australia, 2 months ago

Bayer AG, Boehringer Ingelheim Corporation, Perrigo Company, And Sanofi (France) Linked To Omega Pharma NV Sale; Deal Could Cost More Than $5.3 Billion

Omega Pharma NV, the Belgian over-the-counter health-care company, has attracted interest from companies including Perrigo Co. (PRGO:US) and Germany's Boehringer Ingelheim GmbH, according to people familiar with the matter. Bayer AG (BAYN) and ...
 BioSpace3 days ago Omega Pharma Sale Said to Attract Perrigo and Boehringer  Bloomberg3 days ago

Bayer receives European Commission approval for visual impairment drug

Bayer HealthCare has received the European Commission approval for EYLEA indicated for the treatment of visual impairment due to diabetic macular edema, or DME. Bayer plans for an immediate roll-out with Germany being one of the first launch ...
 Individual.com6 days ago

AWMSG recommends Bayer's Sativex to treat multiple sclerosis

The All Wales Medicines Strategy Group (AWMSG) has recommended Bayer Healthcare's Sativex Oromucosal Spray for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS). Sativex Oromucosal Spray, which ...
 Pharmaceutical Technology1 week ago

Bayer's startup accelerator funds 5 device, healthcare app companies

Fresh off the sales of its interventional device unit to Boston Scientific ($BSX), Bayer Healthcare is showing renewed interest in med tech via its startup accelerator. All 5 of the startups selected for funding, out of 70 applicants, sell a ...
 FierceMedicalDevices2 days ago Bayer HealthCare Launches Digital-Health Accelerator in Berlin  Dow Jones Financial Information Services3 days ago Bayer's Grants4Apps: An accelerator run by a pharma company  Mobihealthnews3 days ago Bayer HealthCare comes full circle with new life science startup accelerator in Berlin  MedCity News4 days ago

Bayer to expand Beijing plant

Bayer HealthCare will invest about 800 million yuan ($130 million) to boost the production capacity of its plant in Beijing. The company held a stone-laying ceremony in the Beijing Economic-Technological Development Area (BDA) in Yizhuang on Aug 18.
 Beijing International6 days ago

Bloomberg: Sale of OTC specialist Omega could top $5.3B with bids from Bayer, Sanofi

Bayer CEO Marijn Dekkers What's an OTC drugmaker worth in the race to the top of the consumer healthcare space? Potentially more than $5.3 billion, if that drugmaker is Belgium's Omega Pharma. The up-for-sale company has so far drawn interest ...
 FiercePharma2 days ago Bloomberg Sale of OTC specialist Omega could top $5.3B with bids from Bayer Sanofi  Big News Network2 days ago

Bayer plans $100 million project in Berkeley — maybe

Bayer HealthCare Pharmaceuticals could spend $100 million to build a product testing facility and raze three buildings in Berkeley, but the drug developer said a final decision on whether to
 Big News Network2 days ago Bayer HealthCare Pharmaceuticals May Add 80,000-Square-Foot Product-Testing Facility In Berkeley, California  BioSpace3 days ago
4 Traders

BAYER : Not intended for U.S. and UK Media - European Society of Cardiology (ESC) Congress 2014: -- New Data on Xarelto® (Rivaroxaban) from Bayer accepted for ESC Congress 2014 Hot Line Session -- Results from X-VeRT, the first prospective study of a nove

- Bayer HealthCare announced today that results from the Phase IIIb exploratory X-VeRT study investigating the oral Factor Xa inhibitor Xarelto® (rivaroxaban) in patients with non-valvular atrial fibrillation (AF) undergoing elective cardioversion ...
 4 Traders1 week ago

Where Are The Opportunities In U.S. Health Care?

By Robert Goldsborough Since the start of 2014, the U.S. health-care sector has continued its recent track record of outpacing the broader U.S. equity market, topping the S&P 500 Index by more than 400 basis points. Over the past three years, ...
 Seeking Alpha4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less